Figure 3.
Outcomes for propensity-matched patients who received RIC. For patients that received RIC, the HR for MUDs compared with Haplos: (A) OS was 0.82 (95% CI, 0.54-1.26), (B) DFS was 0.88 (95% CI, 0.59-1.23), (C) relapse was 1.03 (95% CI, 0.69-1.58), (D) NRM was 0.56 (95% CI, 0.14-0.99), (E) grade 3 to 4 aGVHD was 0.62 (95% CI, 0.1-1.08), and (F) cGVHD was 0.65 (95% CI, 0.34-1.14). BM/PB, bone marrow/peripheral blood; Condition, conditioning; HCT, recipient Sorror comorbidity score; Recip. CMV, recipient CMV status.

Outcomes for propensity-matched patients who received RIC. For patients that received RIC, the HR for MUDs compared with Haplos: (A) OS was 0.82 (95% CI, 0.54-1.26), (B) DFS was 0.88 (95% CI, 0.59-1.23), (C) relapse was 1.03 (95% CI, 0.69-1.58), (D) NRM was 0.56 (95% CI, 0.14-0.99), (E) grade 3 to 4 aGVHD was 0.62 (95% CI, 0.1-1.08), and (F) cGVHD was 0.65 (95% CI, 0.34-1.14). BM/PB, bone marrow/peripheral blood; Condition, conditioning; HCT, recipient Sorror comorbidity score; Recip. CMV, recipient CMV status.

Close Modal

or Create an Account

Close Modal
Close Modal